Current:Home > StocksFDA authorizes Novavax's updated COVID vaccine for fall 2023 -Ascend Finance Compass
FDA authorizes Novavax's updated COVID vaccine for fall 2023
Fastexy View
Date:2025-04-11 04:41:10
The Food and Drug Administration announced Tuesday it had authorized Novavax's updated COVID-19 vaccine, adding a third option for Americans ages 12 and older looking for a new shot this fall and winter.
Novavax's updated shot has been redesigned to target the XBB strains of the virus, similar to the revised formulations from Moderna and Pfizer that were approved last month. The Moderna and Pfizer vaccines are both based on mRNA technology, while Novavax takes a different approach.
"Novavax's authorization today means people will now have the choice of a protein-based non-MRNA option to help protect themselves against COVID-19, which is now the fourth leading cause of death in the U.S.," Novavax's CEO John Jacobs said in a statement.
Closely related descendants of the XBB variant remain the dominant strains of coronavirus circulating nationwide, the Centers for Disease Control and Prevention says.
The FDA's authorization is the last major regulatory hurdle before Novavax's new shots can be rolled out.
"Today's authorization provides an additional COVID-19 vaccine option that meets the FDA's standards for safety, effectiveness and manufacturing quality needed to support emergency use authorization," Dr. Peter Marks, director of the FDA's Center for Biologics Evaluation and Research, said in a release.
At their meeting last month, CDC officials told the agency's Advisory Committee on Immunization Practices that they would not need to reconvene in order to expand recommendations to include Novavax.
The authorization also marks the first time many previously vaccinated Americans will be eligible to get a shot of the protein-based Novavax vaccine, which the company has touted as a "traditional" alternative to Pfizer and Moderna.
Previously, Novavax was only authorized as a first booster dose for people who were unwilling or unable to get an mRNA shot.
When will Novavax's COVID vaccine be available?
Novavax says it has "millions of doses" of its vaccine in the U.S., which will be shipped "in the coming days" once the FDA signs off on each batch.
The company says that doses will be available "at thousands of locations" including national chain drug stores and doctors' offices.
"Once batches are released, we will immediately ship and are working to have product on shelves and ready for administration immediately," a Novavax spokesperson said.
Shots will also be available through the federal Bridge Access and Vaccines for Children program "in the coming days" from Novavax, the company said.
- How to get the new COVID vaccine for free, with or without insurance
- Free COVID test kits are back. Here's how to get them.
For younger children, the company told investors in August that it does not expect authorization of its vaccine until next year.
Why was Novavax's COVID vaccine late?
Authorization of Novavax's shots comes later than the vaccinemaker had hoped. The company's executives previously said they were planning to be in the U.S. market "by September."
It is not clear why Novavax's shot was greenlighted by the FDA later than Pfizer and Moderna.
Cherie Duvall-Jones, an FDA spokesperson, said the authorization "was based on the submission made to the agency by the vaccine manufacturer" and directed further questions to Novavax.
"Novavax worked closely with the FDA on this EUA to ensure that a protein-based option is part of the fall vaccine offering," a spokesperson for Novavax said.
One possible reason could be the timing of the applications.
Moderna submitted applications to the FDA in March and July for their 2023-2024 formula, according to documents published by the agency. Pfizer's were in February and June.
Novavax announced later in August that it had "initiated FDA submission" for their shots.
Officials had previously acknowledged that Novavax's shots could take longer to update for this fall.
The FDA waited until June to lock in their pick for what variant should be targeted by the updated COVID vaccines, in hopes of bettering the odds that the vaccines would be a good match to what was circulating in the fall and winter.
At the time, both health officials and Novavax executives acknowledged that could prove a tight turnaround for non-mRNA vaccines, which take longer to make.
In contrast, picks for strains used in the other traditional protein-based vaccines used for the annual flu shot are made in March in order to allow enough time for approval and manufacturing.
- In:
- COVID-19 Vaccine
- COVID-19
CBS News reporter covering public health and the pandemic.
veryGood! (2)
Related
- Jamie Foxx reps say actor was hit in face by a glass at birthday dinner, needed stitches
- Mississippi city council member pleads guilty to federal drug charges
- Treat Yourself With the Top 28 Trending Beauty Products on Amazon Right Now Starting at Just $1
- Khloe Kardashian Reacts to Comment Suggesting She Should Be a Lesbian
- Warm inflation data keep S&P 500, Dow, Nasdaq under wraps before Fed meeting next week
- Police defend decision not to disclose accidental gunshot during Columbia protest response
- Slain Charlotte officer remembered as hard-charging cop with soft heart for his family
- Three groups are suing New Jersey to block an offshore wind farm
- Spooky or not? Some Choa Chu Kang residents say community garden resembles cemetery
- Jalen Brunson is a true superstar who can take Knicks where they haven't been in decades
Ranking
- Backstage at New York's Jingle Ball with Jimmy Fallon, 'Queer Eye' and Meghan Trainor
- Mariska Hargitay aims criticism at Harvey Weinstein during Variety's Power of Women event
- Commuters cautioned about weekend construction on damaged Interstate 95 in Connecticut
- 'Freedom to Learn' protesters push back on book bans, restrictions on Black history
- Intellectuals vs. The Internet
- More men are getting their sperm checked, doctors say. Should you get a semen analysis?
- Arizona Gov. Katie Hobbs signs bill to repeal 1864 ban on most abortions
- Nordstrom Rack is Heating Up With Swimsuit Deals Starting At $14
Recommendation
The Daily Money: Spending more on holiday travel?
Alaska judge grants limited stay in correspondence school allotments decision
Missouri abortion-rights campaign turns in more than double the needed signatures to get on ballot
Person fatally shot by police after allegedly pointing weapon at others ID’d as 35-year-old man
Jamie Foxx gets stitches after a glass is thrown at him during dinner in Beverly Hills
Captain sentenced to four years following deadly fire aboard dive boat Conception in California
Bryan Kohberger's lawyer claims prosecution has withheld the audio of key video evidence in Idaho murders case
Breaking Down Selling the OC's Feuds: Why Alex Hall and Kayla Cardona Are Not on Speaking Terms